The patent relates to a method of producing an antibody comprising a human variable region and a rodent constant region, i.e. chimeric antibodies.
Brief outline of the case
The patent was revoked and the proprietor appealed.
For the OD, the new MR and AR 1-11 as well as AR 14 contravened Art 123(2).